whitepaper
Why the Need for New Technology in Bio-pharma R&D?
by
Sarabjeet Singh Sharad
30 September 2013
Drug companies nowadays are focusing more on bio-pharma product development. Currently, there are close to 400 biotechnology drug products and vaccines in clinical trials, which are targeting more than 150 diseases. Companies need to manufacture their product candidate under current good manufacturing practice (cGMP) conditions to conduct clinical trials. R&D cost in bio-pharma is high and there is a need for more efficient technology as biologics manufacturing is complex and highly regulated by the FDA.
Leave a comment
Related Insights:
View AllGet more stories like this
Subscirbe for more news,updates and insights from Beroe